Lintel 40 Tablet contains Telmisartan 40 mg, an angiotensin II receptor antagonist used primarily for the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor in vascular smooth muscle, Telmisartan promotes vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This mechanism helps prevent complications associated with hypertension, such as stroke, myocardial infarction, and renal impairment. Lintel 40 is indicated for the treatment of essential hypertension and may be used alone or in combination with other antihypertensive agents. The tablet is administered orally, typically once daily, with or without food, to maintain consistent plasma levels. It is generally well tolerated, with common adverse effects including dizziness, headache, and fatigue. Caution is advised in patients with renal or hepatic impairment, and it is contraindicated during pregnancy due to the risk of fetal toxicity. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Lintel 40 offers an effective option for blood pressure control, contributing to cardiovascular risk reduction when used as part of a comprehensive treatment plan under medical supervision.